Professor Hua Lu received a Medical Bachelor degree from Jiangxi Medical College, China in 1983, a Master of Science degree from Peking Union Medical College in Beijing in 1986, and a PhD degree from Rutgers University/UMDNJ in 1993. After completing his postdoctoral research at Princeton University, he was appointed as a tenure-track Assistant Professor by Oregon Health & Science University (OHSU) in 1997 and promoted to a tenured Associate Professor in 2003. He joined IU as a Full Professor in 2007. Professor Lu is an expert in the fields of protein chemistry and cancer mechanisms involving p53, the most important tumor suppressor. His research has led to the identification of several important protein regulators of p53 as well as its homologs and provides insight into the molecular mechanisms underlying cancer formation. Part of his work will be useful for anti-cancer drug development. His work has resulted in a number of high quality and scientific publications. Professor Lu serves as the editorial board member for Cancer Biology and Therapy, and International Journal of Cancer Research (US), the member of the Tumor Progression and Metastasis study section at the National Institutes of Health, and the Ad Hoc reviewer for many national and international scientific journals, including Nature, Nature Cell Biology, Molecular Cell, Cancer Cell, EMBO J., PNAS, MCB, JCB, JBC, Cancer Research, Oncogene, and Biochemistry, as well as for national and international research funding agents, including the National Institutes of Health, American Cancer Society, National Science Foundation, and research foundations in Canada and UK. He has received the Schering Corp Fellowship for outstanding performance in Biochemistry and Molecular Biology, the postdoctoral fellowship by the Damon Runyon-Walter Winchell Cancer Research Fund and the New Jersey Cancer Research Award for scientific excellence during his postdoctoral work, and the teaching excellence award by OHSU.
Daniel and Lori Efroymson Professor of Oncology